1071 related articles for article (PubMed ID: 18222442)
1. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy.
Ghazale A; Chari ST; Zhang L; Smyrk TC; Takahashi N; Levy MJ; Topazian MD; Clain JE; Pearson RK; Petersen BT; Vege SS; Lindor K; Farnell MB
Gastroenterology; 2008 Mar; 134(3):706-15. PubMed ID: 18222442
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis.
Nishimori I; Otsuki M
Best Pract Res Clin Gastroenterol; 2009; 23(1):11-23. PubMed ID: 19258183
[TBL] [Abstract][Full Text] [Related]
3. IgG4 negative sclerosing cholangitis associated with autoimmune pancreatitis.
Sewkani A; Kapoor S; Sharma S; Naik S; Debbarma MK; Varshney S
JOP; 2005 May; 6(3):269-73. PubMed ID: 15883479
[TBL] [Abstract][Full Text] [Related]
4. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.
Sandanayake NS; Church NI; Chapman MH; Johnson GJ; Dhar DK; Amin Z; Deheragoda MG; Novelli M; Winstanley A; Rodriguez-Justo M; Hatfield AR; Pereira SP; Webster GJ
Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1089-96. PubMed ID: 19345283
[TBL] [Abstract][Full Text] [Related]
5. Analysis of clinical characteristics and treatment of immunoglobulin G4-associated cholangitis: A retrospective cohort study of 39 IAC patients.
Xiao J; Xu P; Li B; Hong T; Liu W; He X; Zheng C; Zhao Y
Medicine (Baltimore); 2018 Feb; 97(8):e9767. PubMed ID: 29465558
[TBL] [Abstract][Full Text] [Related]
6. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis.
Topazian M; Witzig TE; Smyrk TC; Pulido JS; Levy MJ; Kamath PS; Chari ST
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):364-6. PubMed ID: 18328441
[TBL] [Abstract][Full Text] [Related]
7. IgG4-related retroperitoneal fibrosis and sclerosing cholangitis independent of autoimmune pancreatitis. A recurrent case after a 5-year history of spontaneous remission.
Miura H; Miyachi Y
JOP; 2009 Jul; 10(4):432-7. PubMed ID: 19581751
[TBL] [Abstract][Full Text] [Related]
8. Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy.
Björnsson E; Chari S; Silveira M; Gossard A; Takahashi N; Smyrk T; Lindor K
Am J Ther; 2011 May; 18(3):198-205. PubMed ID: 20228674
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
Novotný I; Dítě P; Trna J; Lata J; Husová L; Geryk E
Dig Dis; 2012; 30(2):216-9. PubMed ID: 22722442
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G4-associated cholangitis: one variant of immunoglobulin G4-related systemic disease.
Alderlieste YA; van den Elzen BD; Rauws EA; Beuers U
Digestion; 2009; 79(4):220-8. PubMed ID: 19390194
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Zhang L; Clain JE; Pearson RK; Petersen BT; Vege SS; Farnell MB
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1010-6; quiz 934. PubMed ID: 16843735
[TBL] [Abstract][Full Text] [Related]
12. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma.
Oh HC; Kim MH; Lee KT; Lee JK; Moon SH; Song TJ; Eum J; Park DH; Lee SS; Seo DW; Lee SK
J Gastroenterol Hepatol; 2010 Dec; 25(12):1831-7. PubMed ID: 21091993
[TBL] [Abstract][Full Text] [Related]
13. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis.
Nakazawa T; Ohara H; Sano H; Ando T; Aoki S; Kobayashi S; Okamoto T; Nomura T; Joh T; Itoh M
Pancreas; 2005 Jan; 30(1):20-5. PubMed ID: 15632695
[TBL] [Abstract][Full Text] [Related]
14. IgG4-related sclerosing lymphoplasmacytic pancreatitis and cholangitis mimicking carcinoma of pancreas and Klatskin tumour.
Cheung MT; Lo IL
ANZ J Surg; 2008 Apr; 78(4):252-6. PubMed ID: 18366395
[TBL] [Abstract][Full Text] [Related]
15. Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'.
Uehara T; Hamano H; Kawa S; Sano K; Honda T; Ota H
Pathol Int; 2005 Jul; 55(7):405-11. PubMed ID: 15982215
[TBL] [Abstract][Full Text] [Related]
16. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures.
Erdogan D; Kloek JJ; ten Kate FJ; Rauws EA; Busch OR; Gouma DJ; van Gulik TM
Br J Surg; 2008 Jun; 95(6):727-34. PubMed ID: 18418862
[TBL] [Abstract][Full Text] [Related]
17. IgG4-related sclerosing cholangitis in the absence of autoimmune pancreatitis mimicking extrahepatic cholangiocarcinoma.
Lin J; Cummings OW; Greenson JK; House MG; Liu X; Nalbantoglu I; Pai R; Davidson DD; Reuss SA
Scand J Gastroenterol; 2015 Apr; 50(4):447-53. PubMed ID: 25635498
[TBL] [Abstract][Full Text] [Related]
18. Biliary tract involvement in autoimmune pancreatitis.
Nishino T; Toki F; Oyama H; Oi I; Kobayashi M; Takasaki K; Shiratori K
Pancreas; 2005 Jan; 30(1):76-82. PubMed ID: 15632703
[TBL] [Abstract][Full Text] [Related]
19. Isolated IgG4-related sclerosing cholangitis: a report of 9 cases.
Graham RP; Smyrk TC; Chari ST; Takahashi N; Zhang L
Hum Pathol; 2014 Aug; 45(8):1722-9. PubMed ID: 24890945
[TBL] [Abstract][Full Text] [Related]
20. Measurement of IgG4 in bile: a new approach for the diagnosis of IgG4-associated cholangiopathy.
Vosskuhl K; Negm AA; Framke T; Weismüller T; Manns MP; Wedemeyer H; Plentz RR; Wedemeyer J; Lankisch TO
Endoscopy; 2012 Jan; 44(1):48-52. PubMed ID: 22198775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
